Jef Akst | Jun 15, 2010 | 3 min read
Genetically modifying the stem cells of HIV patients may one day prove to be an effective, one-time therapy against the hard-to-kill virus, according to the results of a proof-of-principle trial published this week in Science Translational Medicine. Human Immunodeficiency VirusImage: Wikimedia commons, NIAIDIn contrast to the widely used highly active antiretroviral therapy (HAART), which patients must continue for their entire lives to control the virus, such a genetic treatment has the potent